Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$1.56
NASDAQLPCN
Open
$1.58
Change
-$0.02 (-1.27%)
Day's Range
$1.52 - $1.60
52-Week Range
$0.31 - $2.40
Volume
846.5K
Market Cap
$102.5M